Magnesium Glycinate Sleep Latency Randomized Trial: What the Evidence Says

Quick Answer

Magnesium Glycinate Sleep Latency Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 1 systematic review, 1 narrative review.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• As such, there is a significant need for an up-to-date review of the evidence on these compounds as they relate to anxiety- and sleep-related symptoms as well as a review of their tolerability and safety.  1 2 3 4 1 3 1 Magnesium is a ubiquitous element both in the earth's geology and human biology. [Muacevic Alexander (2024); evidence level 1]
• While frank deficiency is uncommon (and can result in seizures and arrhythmias among other severe adverse effects), it is thought that upward of half of the United States population does not meet the recommended daily allowance (RDA) for magnesium and is at risk for possible insufficiency. [Muacevic Alexander (2024); evidence level 1]
• Small sample size Short duration High Insomnia 11 Tunc et al 2023 938 279/659 81.1 / R ISI, ESS Elderly outpatient patients / / Hypomagnesemia is Associated with EDS Unknown if EDS leads to hypomagnesemia or vice versa. [He Caijun (2025); evidence level 3]
• Low levels were associated with a higher CRP concentration in patients with OSA. [He Caijun (2025); evidence level 3]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For magnesium glycinate sleep latency randomized trial, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• Muacevic Alexander (2024). Examining the Effects of Supplemental Magnesium on Self-Reported Anxiety and Sleep Quality: A Systematic Review. DOI: 10.7759/cureus.59317. PMCID: PMC11136869. PMID: 38817505. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC11136869/
• He Caijun (2025). The Mechanisms of Magnesium in Sleep Disorders. DOI: 10.2147/NSS.S552646. PMCID: PMC12535714. PMID: 41116797. License: https://creativecommons.org/licenses/by-nc/4.0/ https://www.dovepress.com/terms.php http://creativecommons.org/licens.... https://pmc.ncbi.nlm.nih.gov/articles/PMC12535714/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.